Literature DB >> 25702824

Early Blood Brain Barrier Changes in Acute Ischemic Stroke: A Sequential MRI Study.

Marc Giraud1, Tae-Hee Cho2, Norbert Nighoghossian2, Delphine Maucort-Boulch3, Gianluca Deiana1, Leif Østergaard4, Jean-Claude Baron5, Jens Fiehler6, Salvador Pedraza7, Laurent Derex2, Yves Berthezène1.   

Abstract

BACKGROUND AND
PURPOSE: We sought to identify MRI factors associated with BBB changes at the acute stage of ischemic stroke.
METHODS: We analyzed BBB changes on admission and within 3 hours after the first scan. BBB changes was defined as the presence of leptomeningeal and parenchymal contrast enhancement on T1-weighted imaging. Tmax , CBV, and DWI lesion volume were assessed on baseline MRI. Clinical and MRI factors associated with BBB changes were assessed by univariate and multivariate logistic regressions analyses.
RESULTS: Forty-four patients were included. BBB changes on baseline MRI was observed in 2 of 44 patients (3%). BBB disruption on H3-MRI was present in 19 of 44 patients (43%). Hemodynamic status and baseline ischemic core size were not different between patients with or without BBB changes. BBB alteration on H3 MRI was strongly associated with FLAIR MRI sequence positivity, 16/19 patients (83%) P = .001.
CONCLUSION: BBB changes are exceptional during the first 3 hours after stroke onset. Delayed BBB alteration was associated with FLAIR positivity mainly reflecting vasogenic edema.
Copyright © 2015 by the American Society of Neuroimaging.

Entities:  

Keywords:  Blood brain barrier; MRI; ischemic stroke

Mesh:

Year:  2015        PMID: 25702824     DOI: 10.1111/jon.12225

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  16 in total

1.  Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood-brain barrier.

Authors:  Yutaro Hoshi; Yasuo Uchida; Masanori Tachikawa; Sumio Ohtsuki; Pierre-Olivier Couraud; Takashi Suzuki; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2019-01-09       Impact factor: 6.200

Review 2.  Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.

Authors:  Rais Reskiawan A Kadir; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2019-09-24       Impact factor: 5.046

3.  Hippo/YAP signaling pathway mitigates blood-brain barrier disruption after cerebral ischemia/reperfusion injury.

Authors:  Pian Gong; Zhan Zhang; Changlin Zou; Qi Tian; Xuemei Chen; Michael Hong; Xi Liu; Qianxue Chen; Zhou Xu; Mingchang Li; Jian Wang
Journal:  Behav Brain Res       Date:  2018-08-06       Impact factor: 3.332

Review 4.  Opioid antagonists as potential therapeutics for ischemic stroke.

Authors:  Nadia Peyravian; Emre Dikici; Sapna Deo; Michal Toborek; Sylvia Daunert
Journal:  Prog Neurobiol       Date:  2019-08-06       Impact factor: 11.685

Review 5.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 6.  Improving Reperfusion Therapies in the Era of Mechanical Thrombectomy.

Authors:  Italo Linfante; Marilyn J Cipolla
Journal:  Transl Stroke Res       Date:  2016-05-24       Impact factor: 6.829

Review 7.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

Review 8.  Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design.

Authors:  Luda Feng; Fang Han; Li Zhou; Shengxian Wu; Yawei Du; Dandan Zhang; Chi Zhang; Ying Gao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 9.  Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke.

Authors:  Hrvoje Brzica; Wazir Abdullahi; Kathryn Ibbotson; Patrick T Ronaldson
Journal:  J Cent Nerv Syst Dis       Date:  2017-04-06

Review 10.  How Long Are Reperfusion Therapies Beneficial for Patients after Stroke Onset? Lessons from Lethal Ischemia Following Early Reperfusion in a Mouse Model of Stroke.

Authors:  Takayuki Nakagomi; Yasue Tanaka; Nami Nakagomi; Tomohiro Matsuyama; Shinichi Yoshimura
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.